Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atrial fibrillation.

Wilbert S Aronow1

  • 1Department of Medicine, Westchester Medical Center/New York Medical College, Valhalla, New York 10595, USA. WSAronow@aol.com

Heart Disease (Hagerstown, Md.)
|April 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Journal of the American College of Cardiology·2015
Same author

Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.

International journal of cardiology·2015
Same author

Antiarrhythmic properties of ranolazine: A review of the current evidence.

International journal of cardiology·2015
Same author

Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Hypertension (Dallas, Tex. : 1979)·2015
Same author

Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.

Circulation·2015
Same author

Lipids, blood pressure and kidney update 2014.

Pharmacological research·2015
Same journal

Ximelagatran: a new oral anticoagulant.

Heart disease (Hagerstown, Md.)·2003
Same journal

Long-term (2-4 year) weight reduction with metformin plus carbohydrate-modified diet in euglycemic, hyperinsulinemic, midlife women (Syndrome W).

Heart disease (Hagerstown, Md.)·2003
Same journal

A comparison of humanistic qualities among medical students, residents, and faculty physicians in internal medicine.

Heart disease (Hagerstown, Md.)·2003
Same journal

Effect of carotid angioplasty-stenting on short-term mortality and stroke.

Heart disease (Hagerstown, Md.)·2003
Same journal

Evidence for the extrapulmonary localization of inhaled nitric oxide.

Heart disease (Hagerstown, Md.)·2003
Same journal

Timing and duration of administration are crucial for antiinfarct effect of AMP 579 infused at reperfusion in rabbit heart.

Heart disease (Hagerstown, Md.)·2003
See all related articles

Atrial fibrillation management focuses on rate control and stroke prevention. Treatment options include cardioversion, medications, pacemakers, and anticoagulation like warfarin or aspirin, tailored to patient risk factors.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) prevalence and incidence increase with age.
  • AF is linked to higher risks of coronary events, stroke, and mortality.
  • Rapid ventricular rates in AF can lead to tachycardia-related cardiomyopathy.

Purpose of the Study:

  • To outline current management strategies for atrial fibrillation.
  • To detail pharmacological and non-pharmacological treatment options.
  • To provide guidance on stroke risk management in AF patients.

Main Methods:

  • Review of established guidelines and clinical practices for AF management.
  • Discussion of acute and long-term treatment modalities.
  • Emphasis on individualized patient care based on risk stratification.

Related Experiment Videos

Main Results:

  • Immediate cardioversion is indicated for AF with acute myocardial infarction, hypotension, or severe heart failure.
  • Intravenous and oral medications (beta-blockers, verapamil, diltiazem) are used for rate control.
  • Warfarin or aspirin are recommended for stroke prevention based on risk assessment.

Conclusions:

  • Management of AF involves addressing underlying causes and precipitating factors.
  • Rate control and stroke prevention are key therapeutic goals.
  • Treatment strategies, including anticoagulation and rhythm control, should be individualized.